CG
BVS icon

Cutler Group’s Bioventus BVS Stock Holding History

Cutler Group’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$24K Hold
4,800
– – 0.01% 945
2023
Q4 		$25K Hold
4,800
– – ﹤0.01% 1829
2023
Q3 		$15K Hold
4,800
– – ﹤0.01% 2216
2023
Q2 		$13K Hold
4,800
– – ﹤0.01% 2084
2023
Q1 		$5K Hold
4,800
– – ﹤0.01% 2697
2022
Q4 		$12K Hold
4,800
– – ﹤0.01% 2567
2022
Q3 		$33K Sell
4,800
-54
-1% -$423 ﹤0.01% 2214
2022
Q2 		$33K Hold
4,854
– – ﹤0.01% 2255
2022
Q1 		$68K Sell
4,854
-840
-15% -$11.2K ﹤0.01% 1991
2021
Q4 		$82K Buy
+5,694
New +$80.9K ﹤0.01% 2007

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Cutler Group's BVS Position: Q1 2024 in Review

Cutler Group held its Bioventus (BVS) position steady in Q1 2024 at 4,800 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #945.

Cutler Group first reported a position in BVS in Q4 2021 and has held it in 10 quarters since. The position peaked at $82K in Q4 2021. 84 funds tracked by Wall St. Rank hold BVS as of Q1 2024.

  • Cutler Group held 4,800 shares of Bioventus worth $24K as of Q1 2024.
  • Cutler Group left its Bioventus share count unchanged in Q1 2024.
  • Bioventus made up 0.01% of Cutler Group's portfolio in Q1 2024, its #945 holding.
  • Cutler Group first reported a position in Bioventus in Q4 2021 and has held it in 10 quarters since.
  • Cutler Group's Bioventus position peaked at $82K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.